Deep Dive: Page 2
Industry insights from our journalists
-
Can digital therapeutics become profitable?
As more software-based treatments gain FDA clearance, they still face hurdles ahead in getting insurance reimbursement and garnering adoption among patients and physicians.
Elise Reuter • April 11, 2022 -
‘Where’s the patient?’: Experts question FDA’s final recall guidance
While the guidance encouraged the use of electronic communications in recalls — a change experts have advocated for — some questioned why the agency did not address more problems with the system.
Ricky Zipp • April 6, 2022 -
Hospitals struggle to fill staffing holes in short, long term amid surge in nurse turnover
"This is a bigger workforce shortage than we have ever dealt with," said Gay Landstrom, senior vice president and chief nursing officer of Trinity Health, a nonprofit system with 88 hospitals nationwide.
Hailey Mensik • March 31, 2022 -
Long-term health of patients, hospitals at stake as care delays continue
As federal relief funds dwindle and volumes remain stagnant, concerns are mounting about the stability of many providers' operations, especially those lacking robust outpatient services.
Samantha Liss • March 30, 2022 -
The case for hybrid care models
Telehealth is increasingly being woven into healthcare organizations' future plans, giving hope to proponents of hybrid care models.
Rebecca Pifer • March 22, 2022 -
Threats, obscenities, homicide: Healthcare workers stressed by pandemic face elevated violence
Millions of healthcare workers across the country are becoming inured to workplace violence, which can range from verbal abuse and threats to physical attacks and even homicide.
Hailey Mensik • March 9, 2022 -
Medtech, hospitals on alert for cyberattacks after Russia's invasion of Ukraine
While cybersecurity threats to healthcare and medical devices have grown during the pandemic, the Russia-Ukraine conflict has raised the threat level, putting patient safety at risk.
Greg Slabodkin • Feb. 28, 2022 -
3 key FDA topics for medtechs in 2022
While the agency is looking to get back to normal operations this year, COVID-19 is poised to remain a top priority and, once again, thin resources for more traditional work, such as product reviews.
Ricky Zipp and Greg Slabodkin • Feb. 1, 2022 -
3 key labor trends for hospitals in 2022
Hospitals are still grappling with rising turnover, widespread burnout and numerous staff calling in sick nearly two years after the pandemic began. It's unclear when it might get better — or how much worse it could get.
Hailey Mensik • Jan. 27, 2022 -
4 key trends for procedure-reliant medtechs in 2022
Medical device companies likely will face the same challenges this year that they have been dealing with since the pandemic's start, such as procedure volatility and hospital staffing shortages.
Ricky Zipp • Jan. 27, 2022 -
The shifting digital health investment landscape in 2022
Signs point toward another historic year in VC investment, experts say, which will benefit the medical system as it evolves to include more digital services.
Rebecca Pifer • Jan. 25, 2022 -
Medical device security continues to be casualty of hospital-medtech divide
FDA says manufacturers and hospitals are both responsible for protecting devices from growing cybersecurity threats. However, experts say healthcare providers carry a much heavier load.
Greg Slabodkin • Dec. 1, 2021 -
Why are women more likely to use telehealth?
As Washington mulls over telehealth regulations post-COVID-19, it's important not to roll back access in a way that could disproportionately affect women, experts say.
Rebecca Pifer • Nov. 3, 2021 -
Anatomy of a medical device recall: How defective products can slip through an outdated system
"It truly is like we are operating in about the 1950s," one consultant noted of the process. The FDA has held two meetings in the past year to mull improvements.
Ricky Zipp • Oct. 18, 2021 -
How Morgan Health hopes to finally move the needle on employer health costs: 5 insights from a chat with the venture's CEO
Morgan Health learned a lot from Haven, but is a different beast with better knowledge of the buy-in needed to disrupt the health benefits space, CEO Dan Mendelson told Healthcare Dive.
Rebecca Pifer • Oct. 8, 2021 -
Will a software bill of materials help or hurt medical device cybersecurity?
President Joe Biden's executive order calls for SBOMs, and the FDA wants to require premarket submissions to have an inventory of third-party device components. AdvaMed is concerned the data could be exploited by hackers.
Greg Slabodkin • Oct. 7, 2021 -
Medtechs are boosting DTC investment, but industry still years behind pharma
Companies are spending hundreds of millions of dollars every year on direct-to-consumer advertising as the industry focuses on marketing more to patients.
Ricky Zipp • Sept. 14, 2021 -
Predicting the future of healthcare: 10 takeaways from HIMSS21
Along with "guarded optimism" on the current state of the pandemic, some 19,000 on-site attendees in Las Vegas mulled what's next for AI, telehealth, cybersecurity, mental health and more.
Rebecca Pifer and Hailey Mensik • Aug. 17, 2021 -
Medtech industry starts to face lack of diversity, execs of color
AdvaMed contends the percentage of Black people in leadership roles at device companies has more than doubled from 1.3% to 3.2% since 2015. However, currently none of the largest medtechs has a CEO of color.
Greg Slabodkin • Aug. 12, 2021 -
Diabetes tech companies set sights on Type 2 patients as user numbers climb
With patients flocking to CGMs and insulin pumps over the past several years, companies like Dexcom, Insulet and Tandem are looking to further expand.
Ricky Zipp • Aug. 9, 2021 -
Medtech M&A expected to be robust in second half after 2021 began with a flurry
Even after deals already eclipsed last year's numbers, analysts predict robust activity in particular among diagnostics companies flush with cash from 2020's COVID-19 test sales.
Ricky Zipp • July 18, 2021 -
Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell
Zimmer Biomet had the biggest drop, cutting general payments nearly 80% to $63 million. Other notable decreases include Stryker, J&J's DePuy Synthes and Boston Scientific.
Ricky Zipp • July 12, 2021 -
Legacy medical devices, growing hacker threats create perfect storm of cybersecurity risks
Aging medtech and increasingly sophisticated criminals are leaving hospitals highly vulnerable to attacks.
Greg Slabodkin • June 22, 2021 -
Medtronic HeartWare system hit with slew of Class I recalls, device reports since 2012 PMA
The pump has a higher rate of malfunction reports than rivals, according to an ECRI analysis of the FDA's MAUDE database. But it's hard to draw conclusions from a disparate system of safety reporting.
Ricky Zipp • May 21, 2021 -
Virtual proctoring, training poised to be new normal in post-pandemic surgical interactions
Prior to the COVID-19 public health crisis, momentum to transition operating rooms into digitally connected learning environments was building. Social distancing mandates accelerated those efforts.
Greg Slabodkin • May 19, 2021